An Open Pilot Study of the Combination of Escitalopram and Bupropion-SR for Outpatients With Major Depressive Disorder

OBJECTIVE: Monotherapy with a selective serotonin reuptake inhibitor (SSRI) is the most common initial treatment for major depressive disorder (MDD), but this monotherapy leads to remission in fewer than a third of patients. The combination of the SSRI escitalopram and bupropion-SR is commonly used...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Leuchter, Andrew F., Lesser, Ira M., Trivedi, Madhukar H., Rush, A. John, Morris, David W., Warden, Diane, Fava, Maurizio, Wisniewski, Stephen R., Luther, James F., Gaynes, Bradley N., Stewart, Jonathan W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2778329/
https://ncbi.nlm.nih.gov/pubmed/18832958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.pra.0000336754.19566.65
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados